The well-coordinated efforts by van Embden et al. (5) Dr. Arya raises the interesting issue of the recognition of differences in postvaccination reactogenicities of the various M. bovis BCG strains by polymorphic DNA markers. We have indeed tried to find such genetic differences, using most of the polymorphic genetic markers known for M. tuberculosis complex strains (3). Except for the two M. bovis BCG groups that are distinguished by the presence of either one or two copies of IS6110, we have found a small rearrangement in the chromosomal region that borders one of the copies of this insertion sequence (IS) element. This region contains multiple direct repeats (DRs) of 36 bp, separated by spacer sequences of about the same size (2). This remarkable chromosomal locus is polymorphic among M. tuberculosis complex strains, most likely because of homologous recombination between DRs and because of IS-mediated rearrangements (1).
All 187 isolates (185 from stool samples, 1 from a blood culture, and 1 from a gastric biopsy) requiring H2 were nitrate, reductase, and oxidase positive but negative for urease, catalase, hippurate, and indoxyl acetate. They produced abundant H2S detectable with lead acetate strips and triple sugar iron agar, and they tolerated 1% glycine but not 1.5% NaCl. These characteristics are identical to those for the isolates described by Figura et al. (2) and for C. mucosalis (4, 6) , but unfortunately, they are also identical to the description of Campylobacter concisus (4, 6) . C. concisus has been found in the human mouth and, until recently, has only rarely been isolated from human feces. Using H2-enhanced microaerobic growth conditions, Lauwers et al. (3) isolated 94 strains of C. concisus from the stools of enteritis patients. C. mucosalis strains can be differentiated from C concisus by growth at 25°C, susceptibility to cephalothin, and the production of "dirty yellow" colonies (4, 5) .
Nine of our isolates were determined to be C. mucosalis by the above criteria. Molecular techniques were performed by established procedures. The average mol% G+C value was found to be 38.1, which is the overlap region of the two species (4, 6). DNA-DNA hybridization studies were performed, and the clinical isolates were probed twice, once with the type strain for C. mucosalis, NCTC 11000, and again with the type strain for C. concisus, NCTC 11485. None of the nine isolates reacted with the C. mucosalis probe, while six reacted strongly with the C. concisus probe and three did not react with either probe. These three may represent a new species, as preliminary studies of cellular fatty acid profiles and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) has indicated.
Differentiation of these two species on the basis of growth temperature, cephalothin sensitivity, and colony color is suspect because of strain variability (2, 6). Figura et al. (2) used the API 20 Campy system for confirmation, but we have not found this system completely satisfactory for typing.
Immunotyping (7), SDS-PAGE (1), and, in particular, DNA hybridization studies (5) all allow excellent discrimination between the two species. Indeed, Roop et al. (5) reported that the DNAs from C. mucosalis and C. concisus were only 9% complementary. It is premature to base identification of C mucosalis, which has never been isolated from humans before, solely on a very limited number of variable characteristics. Molecular studies must be done for positive identification.
